These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7737043)

  • 21. Estimation of interindividual pharmacokinetic variability factor for inhaled volatile organic chemicals using a probability-bounds approach.
    Nong A; Krishnan K
    Regul Toxicol Pharmacol; 2007 Jun; 48(1):93-101. PubMed ID: 17367907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of a physiological modeling framework for simulating the toxicokinetics of chemicals in mixtures.
    Haddad S; Charest-Tardif G; Tardif R; Krishnan K
    Toxicol Appl Pharmacol; 2000 Sep; 167(3):199-209. PubMed ID: 10986011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dermal absorption of benzene in occupational settings: estimating flux and applications for risk assessment.
    Williams PR; Sahmel J; Knutsen J; Spencer J; Bunge AL
    Crit Rev Toxicol; 2011 Feb; 41(2):111-42. PubMed ID: 21288163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Uncertainty, variability, and sensitivity analysis in physiological pharmacokinetic models.
    Krewski D; Wang Y; Bartlett S; Krishnan K
    J Biopharm Stat; 1995 Nov; 5(3):245-71. PubMed ID: 8580927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biomonitoring Equivalents for benzene.
    Hays SM; Pyatt DW; Kirman CR; Aylward LL
    Regul Toxicol Pharmacol; 2012 Feb; 62(1):62-73. PubMed ID: 22178585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sensitivity analysis on a physiologically-based pharmacokinetic and pharmacodynamic model for diisopropylfluorophosphate-induced toxicity in mice and rats.
    Chen K; Teo S; Seng KY
    Toxicol Mech Methods; 2009 Oct; 19(8):486-97. PubMed ID: 19788408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dose-dependent metabolism of benzene in hamsters, rats, and mice.
    Mathews JM; Etheridge AS; Matthews HB
    Toxicol Sci; 1998 Jul; 44(1):14-21. PubMed ID: 9720136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of in vitro data in developing a physiologically based pharmacokinetic model: Carbaryl as a case study.
    Yoon M; Kedderis GL; Yan GZ; Clewell HJ
    Toxicology; 2015 Jun; 332():52-66. PubMed ID: 24863738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bayesian estimation of pharmacokinetic and pharmacodynamic parameters in a mode-of-action-based cancer risk assessment for chloroform.
    Liao KH; Tan YM; Conolly RB; Borghoff SJ; Gargas ML; Andersen ME; Clewell HJ
    Risk Anal; 2007 Dec; 27(6):1535-51. PubMed ID: 18093051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biomarkers of environmental benzene exposure.
    Weisel C; Yu R; Roy A; Georgopoulos P
    Environ Health Perspect; 1996 Dec; 104 Suppl 6(Suppl 6):1141-6. PubMed ID: 9118884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New PBPK model applied to old occupational exposure to benzene.
    Sherwood RJ; Sinclair GC
    Am Ind Hyg Assoc J; 1999; 60(2):259-65. PubMed ID: 10222577
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Species differences in the metabolism of benzene.
    Henderson RF
    Environ Health Perspect; 1996 Dec; 104 Suppl 6(Suppl 6):1173-5. PubMed ID: 9118889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NTP Technical Report on the metabolism, toxicity and predicted carcinogenicity of diazoaminobenzene (CAS No. 136-35-6).
    Ress NB;
    Toxic Rep Ser; 2002 Sep; (73):1-23, A1-C6. PubMed ID: 12370695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. S-phenylcysteine in albumin as a benzene biomarker.
    Bechtold WE; Strunk MR
    Environ Health Perspect; 1996 Dec; 104 Suppl 6(Suppl 6):1147-9. PubMed ID: 9118885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The toxicology of benzene.
    Snyder R; Witz G; Goldstein BD
    Environ Health Perspect; 1993 Apr; 100():293-306. PubMed ID: 8354177
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Variability in biological exposure indices using physiologically based pharmacokinetic modeling and Monte Carlo simulation.
    Thomas RS; Bigelow PL; Keefe TJ; Yang RS
    Am Ind Hyg Assoc J; 1996 Jan; 57(1):23-32. PubMed ID: 8588550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterizing uncertainty and variability in physiologically based pharmacokinetic models: state of the science and needs for research and implementation.
    Barton HA; Chiu WA; Setzer RW; Andersen ME; Bailer AJ; Bois FY; Dewoskin RS; Hays S; Johanson G; Jones N; Loizou G; Macphail RC; Portier CJ; Spendiff M; Tan YM
    Toxicol Sci; 2007 Oct; 99(2):395-402. PubMed ID: 17483121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biologically motivated computational modeling of formaldehyde carcinogenicity in the F344 rat.
    Conolly RB; Kimbell JS; Janszen D; Schlosser PM; Kalisak D; Preston J; Miller FJ
    Toxicol Sci; 2003 Oct; 75(2):432-47. PubMed ID: 12857938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bayesian evaluation of a physiologically-based pharmacokinetic (PBPK) model of long-term kinetics of metal nanoparticles in rats.
    Sweeney LM; MacCalman L; Haber LT; Kuempel ED; Tran CL
    Regul Toxicol Pharmacol; 2015 Oct; 73(1):151-63. PubMed ID: 26145831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reverse dosimetry: interpreting trihalomethanes biomonitoring data using physiologically based pharmacokinetic modeling.
    Tan YM; Liao KH; Clewell HJ
    J Expo Sci Environ Epidemiol; 2007 Nov; 17(7):591-603. PubMed ID: 17108893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.